Sponsor Pipeline

Ningbo No.2 Hospital Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
0
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
1
Early Phase 1
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06221462 Neoadjuvant Sintilimab Plus Anlotinib Therapy in IB-IIIB Resectable Non-small Cell Lung… Carcinoma, Non-Small-Cell Lung Not Yet Recruiting
Early Phase 1
NCT07553767 Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related… Hepatocellular Carcinoma Not Yet Recruiting
Not specified
NCT07378124 LLL vs. SDL for LBBP: A Non-inferiority RCT Bradycardia Not Yet Recruiting
NCT07592871 Cohort of Lower-Extremity Sports Injuries and Degeneration(Yongjiang Cohort) Osteoarthritis (OA) of the Knee Not Yet Recruiting
Disease Areas
Get alerts when Ningbo No.2 Hospital's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free